ESC Premium Access

Impact and role of proteomics in cardiovascular disease

Topic: Metabolism and metabolic syndromes


About the speaker

Professor Manuel Mayr

King's British Heart Foundation Centre, London (United Kingdom of Great Britain & Northern Ireland)
9 presentations
1 follower

3 more presentations in this session

Metabolomic profiling in cardiac hypertrophy and failure.

Speaker: Associate Professor C. Perrino (Naples, IT)


Lipidomics to discover new biomarkers for cardiovascular risk

Speaker: Doctor R. Laaksonen (Tampere, FI)


Extra cellular vesicles as biomarkers and novel therapeutic targets.

Speaker: Professor J. Sluijter (Utrecht, NL)


Access the full session

Dissecting the secretome in the "omics" era

Speakers: Professor M. Mayr, Associate Professor C. Perrino, Doctor R. Laaksonen, Professor J. Sluijter

About the event



26 August - 30 August 2017

Sessions Presentations

Related content

Open Access

Integrating EPA based therapy in the management of residual risk.

29 August 2021

Open Access

How the new guidance will impact the treatment of elderly atrial fibrillation patients in clinical practice.

28 August 2021

Open Access

What is new in the 2021 EHRA Practical Guide on the use of NOACs in patients with atrial fibrillation.

28 August 2021

This platform is supported by

logo Novo Nordisk